Overview

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

Status:
NOT_YET_RECRUITING

Trial end date:
2027-08-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986454 in participants with Rheumatoid Arthritis

Phase:

PHASE1

Details

Lead Sponsor:

Bristol-Myers Squibb